4//SEC Filing
Kontulis Caitlin 4
Accession 0001209191-23-010876
CIK 0001533040other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:30 PM ET
Size
5.3 KB
Accession
0001209191-23-010876
Insider Transaction Report
Form 4
Kontulis Caitlin
Secretary & Controller
Transactions
- Tax Payment
Common stock, $0.0001 par value
2023-02-15$5.20/sh−657$3,416→ 7,994 total
Footnotes (2)
- [F1]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
- [F2]Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12.
Documents
Issuer
Phio Pharmaceuticals Corp.
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001570511
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 6:30 PM ET
- Size
- 5.3 KB